Neumora Therapeutics Inc

Research Neumora Therapeutics Inc (NMRA) on Bullrun: market cap USD 318.69M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNMRA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 318.69M
• Financial periodFY2025
• Net incomeUSD 236.93M

Valuation Snapshot

latest market cap is USD 318.69M.

About Neumora Therapeutics Inc

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder.

Frequently asked questions

What is Neumora Therapeutics Inc's market cap?

Neumora Therapeutics Inc's market capitalization is USD 318.69M.

What does Neumora Therapeutics Inc do?

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.